APA (7th ed.) Citation

I, Y., A, D., B, A., C, Y., M, N., AS, Y., & D, S. (2015). Prognostic significance of ASXL1, JAK2V617F mutations and JAK2V617F allele burden in Philadelphia-negative myeloproliferative neoplasms. Journal of blood medicine, 6, 157. https://doi.org/10.2147/JBM.S78826

Chicago Style (17th ed.) Citation

I, Yonal-Hindilerden, Daglar-Aday A, Akadam-Teker B, Yilmaz C, Nalcaci M, Yavuz AS, and Sargin D. "Prognostic Significance of ASXL1, JAK2V617F Mutations and JAK2V617F Allele Burden in Philadelphia-negative Myeloproliferative Neoplasms." Journal of Blood Medicine 6 (2015): 157. https://doi.org/10.2147/JBM.S78826.

MLA (9th ed.) Citation

I, Yonal-Hindilerden, et al. "Prognostic Significance of ASXL1, JAK2V617F Mutations and JAK2V617F Allele Burden in Philadelphia-negative Myeloproliferative Neoplasms." Journal of Blood Medicine, vol. 6, 2015, p. 157, https://doi.org/10.2147/JBM.S78826.